Search Results - Julie Kanter

Current Methods of Newborn Screening Follow-Up for Sickle Cell Disease Are Highly Variable and without Quality Assurance: Results from the ENHANCE Study by Najibah Galadanci, Shannon Phillips, Alyssa Schlenz, Nataliya Ivankova, Julie Kanter

Connect to this object online.

Newborn Screening for Sickle Cell Disease in St. Vincent and the Grenadines: Results of a Pilot Newborn Screening Program by Shelly-Ann Williams MD, Beneka Browne-Ferdinand MD, Ynolde Smart SCM, PHN, Kristen Morella MPH, Susan G. Reed DDS, DrPH, Julie Kanter MD

Connect to this object online.

Barriers to Pediatric Sickle Cell Disease Guideline Recommendations by Michael D. Cabana MD, MPH, Julie Kanter MD, Anne M. Marsh MD, Marsha J. Treadwell PhD, Michael Rowland MPH, Peggy Stemmler MD, Naomi S. Bardach MD, MAS

Connect to this object online.

Evaluating the Discriminatory Ability of the Sickle Cell Data Collection Program's Administrative Claims Case Definition in Identifying Adults With Sickle Cell Disease: Validation... by Ashima Singh, Marci K Sontag, Mei Zhou, Mahua Dasgupta, Tessa Crume, Morgan McLemore, Najibah Galadanci, Eldrida Randall, Nicole Steiner, Amanda M Brandow, Kathryn Koch, Joshua J Field, Kathryn Hassell, Angela B Snyder, Julie Kanter

Connect to this object online.

Social determinants of health and treatment center affiliation: analysis from the sickle cell disease implementation consortium registry by Gustavo G. Mendez, Judith M. Nocek, Donald J. Brambilla, Sara Jacobs, Oladipo Cole, Julie Kanter, Jeffrey Glassberg, Kay L. Saving, Cathy L. Melvin, Robert W. Gibson, Marsha Treadwell, George L. Jackson, Allison A. King, Victor R. Gordeuk, Barbara Kroner, Lewis L. Hsu, Sickle Cell Disease Implementation Consortium

Connect to this object online.